×
About 328 results

ALLMedicine™ Kaposiform Hemangioendothelioma Center

Research & Reviews  119 results

Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.
https://clinicaltrials.gov/ct2/show/NCT04775173

Jan 18th, 2023 - Kaposiform hemangioendothelioma (KHE) is a rare aggressive vascular neoplasm that occurs predominantly in infancy or early childhood, with an incidence of approximately 0.71/100,000. Currently, sirolimus is a promising treatment modality for KHE. ...

Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma
https://clinicaltrials.gov/ct2/show/NCT04056962

Jan 18th, 2023 - Kaposiform hemangioendothelioma (KHE) and tufted angiomas (TA) are rare vascular tumors, which are apparent predominantly in infancy or early childhood. Currently, no standard treatment regimens exist for KHE/TA. The aim of this study was to evalu...

Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies
https://clinicaltrials.gov/ct2/show/NCT04921722

Jan 11th, 2023 - Vascular anomaly is a kind of rare disease. According to histology, biological behavior and clinical manifestations, it can be divided into two categories: vascular tumor and vascular malformation. mTOR inhibitors are proved with the properties of...

Composite hemangioendothelioma in the cervical spine with kaposiform hemangioendothelio...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733294
BMC Geriatrics; Nakamura S, Uehara M et. al.

Dec 11th, 2022 - Composite hemangioendothelioma (CHE) is an intermediate group of tumors with features between hemangioma and angiosarcoma both histologically and biologically. CHE is predominant in young and middle-aged adults, but very infrequently affects the s...

Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
https://clinicaltrials.gov/ct2/show/NCT04077515

Dec 6th, 2022 - The clinically commonly used dose of sirolimus for Kaposiform Hemangioendothelioma is 0.8 mg/m2 administered twice daily, and the blood concentration can be maintained at 10-15 ng/ml according to the pharmacokinetic formula.Related research report...

see more →

Clinicaltrials.gov  9 results

Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.
https://clinicaltrials.gov/ct2/show/NCT04775173

Jan 18th, 2023 - Kaposiform hemangioendothelioma (KHE) is a rare aggressive vascular neoplasm that occurs predominantly in infancy or early childhood, with an incidence of approximately 0.71/100,000. Currently, sirolimus is a promising treatment modality for KHE. ...

Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma
https://clinicaltrials.gov/ct2/show/NCT04056962

Jan 18th, 2023 - Kaposiform hemangioendothelioma (KHE) and tufted angiomas (TA) are rare vascular tumors, which are apparent predominantly in infancy or early childhood. Currently, no standard treatment regimens exist for KHE/TA. The aim of this study was to evalu...

Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies
https://clinicaltrials.gov/ct2/show/NCT04921722

Jan 11th, 2023 - Vascular anomaly is a kind of rare disease. According to histology, biological behavior and clinical manifestations, it can be divided into two categories: vascular tumor and vascular malformation. mTOR inhibitors are proved with the properties of...

Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
https://clinicaltrials.gov/ct2/show/NCT04077515

Dec 6th, 2022 - The clinically commonly used dose of sirolimus for Kaposiform Hemangioendothelioma is 0.8 mg/m2 administered twice daily, and the blood concentration can be maintained at 10-15 ng/ml according to the pharmacokinetic formula.Related research report...

Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma
https://clinicaltrials.gov/ct2/show/NCT04448873

Oct 24th, 2022 - Kaposiform Hemangioendothelioma (KHE) is a rare vascular tumor that occurs in infants and children. KHE is characterized by sheets of spindle cells with an infiltrative pattern in the dermis, subcutaneous fat, and muscle. It is locally aggressive ...

see more →

News  3 results

An infant girl presents with a growing pink-red leg nodule
https://www.mdedge.com/pediatrics/article/240107/dermatology/infant-girl-presents-growing-pink-red-leg-nodule
Lawrence Eichenfield, MD, Michael Haft, BA, MS4

May 13th, 2021 - The history of a brownish to pink patch with color change and rapid growth within the first year combined with the exam findings, are suggestive of a tufted angioma, though the findings presented may be nonspecific. Dr.

Neonatal Consultations: Vascular Lumps, Bumps, and Tumors in the Neonate
https://www.mdedge.com/dermatology/article/211333/pediatrics/neonatal-consultations-vascular-lumps-bumps-and-tumors-neonate
Minnelly Luu, MD

Oct 31st, 2019 - Although most neonatal vascular lumps, bumps, and tumors are benign, proper diagnosis is important for prognosis and management. Therefore, knowledge of both common and rare conditions is important when evaluating a neonatal nodule.

A 7-Week-Old Infant With a Large Facial Hemangioma
https://www.medscape.com/viewarticle/715477

Jan 27th, 2010 - History and Clinical Presentation A 7-week-old white infant girl presented to pediatric dermatology with a large facial hemangioma. The mother first noticed redness on the infant's left upper forehead at 2-3 days of age, and the lesion has been gr...

see more →